UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 308

Sortiert nach

Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial

Gut, 2004-10, Vol.53 (10), p.1459-1464

2004

Volltextzugriff (PDF)

The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects

Alimentary pharmacology & therapeutics, 2003-03, Vol.17 (5), p.643-650

2003

Volltextzugriff (PDF)

Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN‐173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation

Alimentary pharmacology & therapeutics, 2009-01, Vol.29 (1), p.104-114

2009

Volltextzugriff (PDF)

Visceral hypersensitivity in endometriosis: a new target for treatment?

Gut, 2012-03, Vol.61 (3), p.367-372

2012

Volltextzugriff (PDF)

The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress

Alimentary pharmacology & therapeutics, 1997-04, Vol.11 (2), p.395-402

1997

Volltextzugriff (PDF)

Review article: abdominal bloating and distension in functional gastrointestinal disorders – epidemiology and exploration of possible mechanisms

Alimentary pharmacology & therapeutics, 2008-01, Vol.27 (1), p.2-10

2008

Volltextzugriff (PDF)

Long term benefits of hypnotherapy for irritable bowel syndrome

Gut, 2003-11, Vol.52 (11), p.1623-1629

2003

Volltextzugriff (PDF)

Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component?

Gut, 2003-01, Vol.52 (1), p.91-93

2003

Volltextzugriff (PDF)

Effect of a second-generation α2δ ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndrome

Gut, 2007-09, Vol.56 (9), p.1218-1225

2007

Volltextzugriff (PDF)

Conducting multinational, cross‐cultural research in the functional gastrointestinal disorders: issues and recommendations. A Rome Foundation working team report

Alimentary pharmacology & therapeutics, 2014-11, Vol.40 (9), p.1094-1102

2014

Volltextzugriff (PDF)

Irritable bowel syndrome: the problem and the problem of treating it – is there a role for probiotics?

Proceedings of the Nutrition Society, 2014-11, Vol.73 (4), p.470-476

2014

Volltextzugriff (PDF)

Irritable bowel syndrome: diagnosis and management

BMJ (British Medical Journal), 2006-02, Vol.332 (7536), p.280-283

International edition, 2006

Volltextzugriff (PDF)

The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteers

Gut, 2002-04, Vol.50 (4), p.471-474

2002

Volltextzugriff (PDF)

Editorial: preventing unnecessary investigation and surgery in the irritable bowel syndrome—the critical role of the general practitioner

Alimentary pharmacology & therapeutics, 2018-06, Vol.47 (11), p.1558-1559

Whorwell, P. J.

2018

Volltextzugriff (PDF)

Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome

Gut, 2003-05, Vol.52 (5), p.663-670

2003

Volltextzugriff (PDF)

Unraveling functional abdominal bloating and distension: the role of thoraco-abdominal accommodation and a physical sign to aid its detection

Neurogastroenterology and motility, 2012-04, Vol.24 (4), p.301-304

Whorwell, P. J.

2012

Volltextzugriff (PDF)

Tegaserod for the treatment of irritable bowel syndrome and chronic constipation

Cochrane database of systematic reviews, 2007-10 (4), p.CD003960

2007

Volltextzugriff (PDF)

Minor digestive symptoms and their impact in the general population: a cluster analysis approach

Therapeutic advances in gastroenterology, 2018-01, Vol.11, p.1756284818768814-1756284818768814

2018

Volltextzugriff (PDF)

Review article: the history of hypnotherapy and its role in the irritable bowel syndrome

Alimentary pharmacology & therapeutics, 2005-12, Vol.22 (11‐12), p.1061-1067

WHORWELL, P. J.

2005

Volltextzugriff (PDF)

Gut‐focused hypnotherapy normalizes disordered rectal sensitivity in patients with irritable bowel syndrome

Alimentary pharmacology & therapeutics, 2003-03, Vol.17 (5), p.635-642

2003

Volltextzugriff (PDF)

Reactivity to images in health and irritable bowel syndrome

Alimentary pharmacology & therapeutics, 2010-01, Vol.31 (1), p.131-142

2010

Volltextzugriff (PDF)

Tegaserod for the treatment of irritable bowel syndrome

Cochrane database of systematic reviews, 2004 (1), p.CD003960

2004

Volltextzugriff (PDF)

Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients

Alimentary pharmacology & therapeutics, 2015-05, Vol.41 (9), p.844-855

2015

Volltextzugriff (PDF)

Towards a better understanding of abdominal bloating and distension in functional gastrointestinal disorders

Neurogastroenterology and motility, 2005-08, Vol.17 (4), p.500-511

2005

Volltextzugriff (PDF)

Abdominal Bloating and Distension: What Is the Role of the Microbiota

Digestive diseases and sciences, 2012, Vol.57 (1), p.4-8

2012

Volltextzugriff (PDF)

1 – 25 von 308

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(290)
Mit Volltextzugriff
(247)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(210)
Science & Technology
(192)
Life Sciences & Biomedicine
(191)
Gastroenterology & Hepatology
(135)
Female
(120)
Adult
(110)
Biological And Medical Sciences
(101)
Male
(98)
Medical Sciences
(98)
Middle Aged
(90)
Irritable Bowel Syndrome
(78)
Gastroenterology. Liver. Pancreas. Abdomen
(61)
Other Diseases. Semiology
(58)
Aged
(57)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(56)
General & Internal Medicine
(36)
Medicine, General & Internal
(36)
Pharmacology & Pharmacy
(34)
Adolescent
(33)
Digestive System
(27)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Gut
(68)
Alimentary Pharmacology & Therapeutics
(36)
The Lancet
(28)
Gastroenterology
(18)
Digestion
(16)
Bmj
(15)
Bmj. British Medical Journal
(15)
The American Journal Of Gastroenterology
(15)
British Medical Journal
(11)
Neurogastroenterology And Motility
(11)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial

The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects

Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN‐173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation

Visceral hypersensitivity in endometriosis: a new target for treatment?

The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress

Review article: abdominal bloating and distension in functional gastrointestinal disorders – epidemiology and exploration of possible mechanisms

Long term benefits of hypnotherapy for irritable bowel syndrome

Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component?

Effect of a second-generation α2δ ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndrome

Conducting multinational, cross‐cultural research in the functional gastrointestinal disorders: issues and recommendations. A Rome Foundation working team report

Irritable bowel syndrome: the problem and the problem of treating it – is there a role for probiotics?

Irritable bowel syndrome: diagnosis and management

The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteers

Editorial: preventing unnecessary investigation and surgery in the irritable bowel syndrome—the critical role of the general practitioner

Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome

Unraveling functional abdominal bloating and distension: the role of thoraco-abdominal accommodation and a physical sign to aid its detection

Tegaserod for the treatment of irritable bowel syndrome and chronic constipation

Minor digestive symptoms and their impact in the general population: a cluster analysis approach

Review article: the history of hypnotherapy and its role in the irritable bowel syndrome

Gut‐focused hypnotherapy normalizes disordered rectal sensitivity in patients with irritable bowel syndrome

Reactivity to images in health and irritable bowel syndrome

Tegaserod for the treatment of irritable bowel syndrome

Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients

Towards a better understanding of abdominal bloating and distension in functional gastrointestinal disorders

Abdominal Bloating and Distension: What Is the Role of the Microbiota

Suchergebnisse filtern